RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL
· Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Aug 15, 2025, 3:59 PM
1.39
1.36%
After-hours: Aug 15, 2025, 06:45 PM EDT
RedHill Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.27M | -19.22M | -30.17M | -27.87M | 23.92M | 33.73M | 11.57M | -900K | -68.28M | -88.92M | -74.61M | -92.02M | -97.74M | -97.7M | -94.95M | -81.88M |
Depreciation & Amortization | 619K | 721K | 823K | -58.29M | 1.99M | 3.8M | 5.68M | 66.5M | 8.15M | 17.34M | 17.59M | 17.97M | 18.15M | 9.51M | 9.74M | 9.64M |
Stock-Based Compensation | 665K | 846K | 1.03M | 1.62M | 1.65M | 2.38M | 3.6M | 3.51M | 5.67M | 6.41M | 6.99M | 11.65M | 10.21M | 9.42M | 8.92M | 4.27M |
Other Working Capital | 3.37M | -1.93M | -7.23M | -6.51M | -37.23M | -31.35M | -24.16M | -24.19M | 11.1M | 12.04M | 8.29M | 8M | 10.04M | 43.36M | 36.19M | 62.15M |
Other Non-Cash Items | -6.55M | 857K | 8.26M | 57.97M | -59.34M | -73.05M | -55.06M | -103.29M | 20.64M | 27.4M | 2.66M | 5.92M | 5.49M | 7.47M | 8.66M | 8.9M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 41K | 58K | 75K | 123K | 373K | 392K | 331K |
Change in Working Capital | 4.16M | -2.5K | -4.17M | -5.16M | -4.03M | 3.92M | 7.98M | 1.96M | 4.62M | -3.86M | -7.26M | -457K | -1.15M | 8.41M | 14.58M | 9.9M |
Operating Cash Flow | -9.37M | -16.8M | -24.23M | -31.73M | -35.82M | -29.22M | -26.22M | -32.22M | -29.18M | -41.62M | -54.62M | -56.94M | -65.05M | -62.9M | -53.04M | -49.17M |
Capital Expenditures | -9K | -7K | -5K | -11.5K | -11K | -10.34K | -30.34K | -186.34K | -199.34K | -201K | -200K | -40K | -115K | -161K | -1.04M | -53.56M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.5M | -5M | -8.5M | -8.5M | -12M | -3.5M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | -8.5M | -8.56M | -8.61M | -109.08K | 8.39M | 8.45M | 8.51M | 480.25K | 8.38M | 10.45M | 13.18M |
Other Investing Acitivies | n/a | 7.5K | 15K | 15K | 15K | 8.84K | 57.01K | 110.41K | 8.61M | 12.11M | 3.55M | n/a | -8.03M | -3.63M | 4.14M | -44.86M |
Investing Cash Flow | -9K | 500.00 | 10K | 3.5K | 4K | -8.5M | -8.53M | -8.69M | -198K | 11.8M | 3.3M | -40K | -8.14M | -3.79M | 5.91M | -40.38M |
Debt Repayment | n/a | n/a | n/a | -293K | -589K | -973K | -1.59M | -1.66M | -1.48M | -1.54M | -1.37M | -1.41M | -1.68M | -1.65M | -1.99M | -2.5M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8.42M | 16.47M | 24.53M | 22.48M | 16.93M | 8.62M | -4.69M | -6.83M | -10.77M | -12.57M | -8.63M | -10.04M | -3.39M | -1.59M | 3.06M | 4.7M |
Financial Cash Flow | 8.42M | 16.47M | 24.53M | 20.58M | 21.44M | 20.33M | 6.29M | 21.21M | 11.45M | 21.82M | 26.55M | 9.86M | 73.46M | 63.83M | 76.79M | 84.02M |
Net Cash Flow | n/a | n/a | -7M | -17.57M | -19.97M | -15.2M | -19.99M | -11.28M | -9.51M | -8.05M | -24.83M | -47.13M | 179K | -2.94M | 29.54M | -5.64M |
Free Cash Flow | -9.38M | -16.81M | -24.23M | -31.74M | -35.83M | -29.23M | -26.25M | -32.4M | -29.38M | -41.82M | -54.82M | -56.98M | -65.16M | -63.06M | -54.08M | -102.73M |